Table III.
General description of the study population according the treatment response.
| Variable | Responders | Non-responders | P-valuea |
|---|---|---|---|
| n (%) | 17 (65.4) | 9 (34.6) | |
| Age, years (Mean ± SD) | 36.4±14.3 | 35.2±13.2 | 0.850a |
| Sex, male/female ratio | 12/5=2.4 | 5/4=1.25 | 0.528b |
| Myocarditis | |||
| Active, n (%) | 11 (64.7) | 5 (55.6) | 0.692b |
| Borderline, n (%) | 6 (35.3) | 4 (44.4) | 0.692b |
| Treatment | |||
| Immunosuppressive, n (%) | 14 (82.4) | 8 (88.9) | 0.569b |
| Conventional, n (%) | 3 (17.6) | 1 (11.1) | 0.569b |
| Cardiovascular risk factors | |||
| Diabetes mellitus, n (%) | 1 (5.9) | 0 (0) | 0.654b |
| Systemic hypertension, n (%) | 2 (11.8) | 1 (11.1) | 0.732b |
| Dyslipidemia, n (%) | 5 (29.4) | 0 (0) | 0.129b |
| Smoking, n (%) | 7 (41.2) | 4 (44.4) | 0.598b |
| Body mass index (kg/m2), median (range) | 26.5 (18.8–39.4) | 27.7 (22.4–29) | 0.957a |
| Antecedent of recent infection | |||
| Airways, n (%) | 10 (58.8) | 4 (44.4) | 0.683b |
| Gastrointestinal, n (%) | 2 (11.8) | 0 (0) | 0.529b |
a
Mann-Whitney U test.
b
Fisher exact test.